- Medical Devices
- Wednesday, 24 Jun 2020
Senzime Expands US Sales Team and Signs Additional Distribution Agreements
"I am proud to say that our strategy is now materializing in the US. Bringing distributors Clinical Technology and Co-Medical on board together with a direct sales team gives us a strong and agile position to transform the US market and introduce the cutting-edge TetraGraph technology to physicians nationwide", says Pia Renaudin, CEO Senzime.
Senzime Inc.'s President & General Manager Christopher Estes has together with Neal Smith, US VP Sales initiated the recruitment of a direct sales force that will be ready to meet accumulated demands as US hospitals now are restarting elective surgery procedures.
The US is the largest medical device market in the world representing 40 percent of global sales. By 2023, it is expected to grow to $208 billion. The country has more than 6,000 hospitals.
Senzime's TetraGraph neuromuscular monitor is a unique digital system designed to address the needs of perioperative monitoring of physiologic data in surgical patients receiving general anesthesia and muscle relaxation using neuromuscular blocking drugs (NMBAs). The TetraGraph is based on over 10 years of R&D and uses advanced algorithms and EMG-technology to stimulate, analyze and display the patient's muscle function in real-time.
Related Industry Updates
IRRAflow® Wins CONNECT's "2019 Most Innovative New Product" Award
Dec 09, 2019
Emerging Trends in Global Regions to Play a Significant Role in Growth of the Healthcare Tele-Consultation Services Market
May 11, 2021
Automated Radiosynthesis Modules Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By End User (Ambulatory Surgical Centers, Diagnostics Labs, Hospitals, and Radiology Clinics) and Geography
Apr 28, 2021
Pediatric MRI Market is expected to reach US$ 5,678.86 million by 2028
Jul 04, 2023
Electrical Stimulation Devices Market Innovations, Competitive Analysis, New Business Developments and Top Companies – Global Forecast to 2027
Aug 17, 2020
US Lymphedema Treatment Market is expected to reach US$ 8,320.07 million by 2028
May 12, 2023
Europe Diabetes Care Devices Market is expected to reach US$ 4.3 Billion by 2027 with CAGR of 16.2%
Jul 23, 2020